Nachrichten zur AstraZeneca PLC Aktie

AstraZeneca hikes annual profit outlook…

AstraZeneca 9 November 2023 9M and Q3 2023 results Strong momentum in the year to date leads to increased guidance for Total Revenue…

AstraZeneca reports, Li Auto earnings, Tapestry: 3 things to watch…

…

Viele Unternehmen, unter anderem Merck KGaA, Sony, Astrazeneca, legen heute ihre Zahlen vor. Außerdem stehen wichtige Wirtschaftsdaten aus China, Japan…

The U.S. Federal Trade Commission (FTC) on Tuesday said it sent notice letters to Abbvie , AstraZeneca , Teva and…

FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Astrazeneca auf "Hold" mit einem Kursziel von 11000 Pence…

Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The "Asia Cervical Cancer Screening Market, Size, Forecast 2023-2028, Industry Trends,…

Higher sales of AstraZenecas (AZN) key medicines, Lynparza, Tagrisso, Imfinzi and Farxiga, are likely to have driven sales in the…

1 November 2023 15:00 GMT Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct…

The U.S.-listed shares of Cellectis S.A. CLLS rocketed 179.3% on very heavy volume in premarket trading Wednesday, after the France-based…

…

DJ Astrazeneca investiert 245 Millionen Dollar in Deal mit Cellectis Von Ben Otto LONDON (Dow Jones)--Der britische Pharmakonzern Astrazeneca will…

NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS – NASDAQ: CLLS) today announced it…

01 November 2023 AstraZeneca announces collaboration and investment agreement with Cellectis to accelerate cell therapy and genomic medicine ambitions Collaboration leverages the…

If approved, AstraZeneca’s nasal spray vaccine would become the first flu vaccine authorized for self-administration in the U.S.…

Employers which pay staff the Real Living Wage (RLW) will have to find an extra 10% after it was increased…

AstraZeneca PLC AZNUK:AZN said Tuesday the U.S. Food and Drug Administration has accepted its application for approval of a self-administered…

LumiraDx surges after partnering with AstraZeneca, Everton on Englands first heart and lung screening hub…

…

Dublin, Oct. 23, 2023 (GLOBE NEWSWIRE) -- The "Medical Courier Market Size and Forecasts 2020-2030, Global and Regional…

Press release Nanoform Finland Plc October 23, 2023 08:10 Finnish time / 07:10 Swedish time Nanoform grant Global STARMAP[®] AI License to AstraZeneca Helsinki, Finland…

LONDON, Oct. 20, 2023 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care diagnostics company,…

…

New York (www.aktiencheck.de) - Rating-Update: Seamus Fernandez, Analyst von Guggenheim Securities, stuft die Aktie des Pharmakonzerns AstraZeneca plc (ISIN: GB0009895292, WKN:…

…

NIH data show that globally less than 2% of genetic information being studied today originates from people of African ancestry1…

AstraZeneca shares fall as abstract for lung cancer trial data disappoints…

Shares in AstraZeneca fell more than 4% on Wednesday after the publication of an abstract on its experimental precision drugs…

The FDA accepts and grants priority review to AstraZenecas (AZN) sNDA, seeking approval of Tagrisso combined with chemotherapy as a…

[235 + Pages Report] According to a market research study published by The Brainy Insights, the demand analysis of Global…

MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH.R&D Postdoctoral Challenge ist eine einzigartige Initiative…

Todays Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Chevron Corporation (CVX) and…

…

FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Astrazeneca auf "Hold" mit einem Kursziel von 11000 Pence…

Gruppe um Air France-KLM steigt bei skandinavischer Airline SAS einAstraZeneca hat sich bereit erklärt, 425 Mio USD zu zahlen, um…

Despite overall biologic growth in both geographies, use of advanced systemic treatments in the US outpaces the EU5. Despite overall…

Company to Host Cancer R&D Update on October 19, 2023 to Share Latest Details of Multipronged Cancer Program Based on…

DJ Astrazeneca legt Nexium- und Prilosec-Klagen gegen Millionenzahlung bei Von Michael Susin FRANKFURT (Dow Jones)--Der Pharmakonzern Astrazeneca legt US-Produkthaftungsklagen im…

AstraZeneca to pay $425 million to settle Nexium, Prilosec litigation in US…

3 October 2023 AstraZeneca settles Nexium and Prilosec product liability litigations AstraZeneca has entered into settlement agreements in the product liability litigations related to Nexium and Prilosec. The agreements…

2 October 2023 15:00 BST Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct…

A deadline looms to sign drug-price negotiation agreements as industry watches for legal reprieve.…

The dynamics of the eosinophilic esophagitis market are anticipated to change in the coming years owing to the expected launch…

AstraZeneca, Boehringer Ingelheim and other drugmakers have filed at least eight lawsuits seeking to declare the Medicare price talks unconstitutional.…

[230+ Pages Report] According to a market research study published by The Brainy Insights, the demand analysis of Global…

AstraZeneca is the largest foreign owned pharmaceutical company in China based on revenue, and they’re continuing to increase investment in…

…

The dynamics of the chronic obstructive pulmonary disease market are anticipated to change in the coming years owing to the…

AstraZeneca growth opportunities overlooked - Jefferies…